ACADIA Pharmaceuticals Inc. vs American Well Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while American Well Corp trades at $13.26 (market cap $220.94M). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 22.9× American Well Corp's market cap. Which is the better fit depends on your goals.
| ACAD | AMWL | |
|---|---|---|
Market Cap | $5.07B | $220.94M |
Sector | Health | Health |
52-Week High | $29.41 | $13.58 |
52-Week Low | $20.06 | $3.78 |
Enterprise Value | $4.19B | $27.98M |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →